Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131717) titled 'Development of an Ultrasensitive Detection System for the Human Myeloid Tumor Marker Gene WT1 and Establishment of Its Reference Range' on Sept. 6.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Beijing Hospital

Condition: None

Intervention: Adult Male Group:None Adult Female Group:None Elderly Male Group (65-80 years):None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-01-12

Target Sample Size: Adult Male Group:155;Adult Female Group:155;Elderly Male Group (65-80 years):155;Elderly Female Group (65-80 years):155;

Countries of Recruitment:...